149 related articles for article (PubMed ID: 11959597)
1. Activities of new fluoroquinolones, ketolides, and other antimicrobials against blood culture isolates of viridans group streptococci from across Canada, 2000.
Gershon AS; de Azavedo JC; McGeer A; Ostrowska KI; Church D; Hoban DJ; Harding GK; Weiss K; Abbott L; Smaill F; Gourdeau M; Murray G; Low DE;
Antimicrob Agents Chemother; 2002 May; 46(5):1553-6. PubMed ID: 11959597
[TBL] [Abstract][Full Text] [Related]
2. In vitro activities of fluoroquinolones against antibiotic-resistant blood culture isolates of viridans group streptococci from across Canada.
de Azavedo JC; Trpeski L; Pong-Porter S; Matsumura S; Low DE
Antimicrob Agents Chemother; 1999 Sep; 43(9):2299-301. PubMed ID: 10471583
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of ABT-773, telithromycin and eight other antimicrobials against erythromycin-resistant Streptococcus pneumoniae respiratory isolates of children.
Johnson CN; Benjamin WH; Gray BM; Crain MC; Edwards KM; Waites KB
Int J Antimicrob Agents; 2001 Dec; 18(6):531-5. PubMed ID: 11738340
[TBL] [Abstract][Full Text] [Related]
4. [In vitro activity of six fluoroquinolones and penicillin against 101 viridans group streptococci characterized by their susceptibility to erythromycin].
Rodríguez-Avial I; Rodríguez-Avial C; Picazo JJ
Rev Esp Quimioter; 2001 Dec; 14(4):364-8. PubMed ID: 11856983
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of gemifloxacin (SB-265805) compared to eleven other antimicrobial agents against streptococcal isolates, excluding Streptococcus pneumoniae.
Kerawala M; Ambler JE; Lee PY; Drabu YJ
Eur J Clin Microbiol Infect Dis; 2001 Apr; 20(4):271-5. PubMed ID: 11399019
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002.
Zhanel GG; Palatnick L; Nichol KA; Bellyou T; Low DE; Hoban DJ
Antimicrob Agents Chemother; 2003 Jun; 47(6):1867-74. PubMed ID: 12760860
[TBL] [Abstract][Full Text] [Related]
7. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
Mazzariol A; Koncan R; Vitali LA; Cornaglia G
J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of the new ketolide HMR 3647 (telithromycin) in comparison with those of eight other antibiotics against viridans group Streptococci isolated from blood of neutropenic patients with cancer.
Alcaide F; Benítez MA; Carratalà J; Gudiol F; Liñares J; Martín R
Antimicrob Agents Chemother; 2001 Feb; 45(2):624-6. PubMed ID: 11158768
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species.
Jalava J; Kataja J; Seppälä H; Huovinen P
Antimicrob Agents Chemother; 2001 Mar; 45(3):789-93. PubMed ID: 11181362
[TBL] [Abstract][Full Text] [Related]
10. Comparison of in vitro activities of ABT-773 and telithromycin against macrolide-susceptible and -resistant streptococci and staphylococci.
Shortridge VD; Zhong P; Cao Z; Beyer JM; Almer LS; Ramer NC; Doktor SZ; Flamm RK
Antimicrob Agents Chemother; 2002 Mar; 46(3):783-6. PubMed ID: 11850262
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors.
Bemer-Melchior P; Juvin ME; Tassin S; Bryskier A; Schito GC; Drugeon HB
Antimicrob Agents Chemother; 2000 Nov; 44(11):2999-3002. PubMed ID: 11036012
[TBL] [Abstract][Full Text] [Related]
12. Antipneumococcal activities of gemifloxacin compared to those of nine other agents.
Davies TA; Kelly LM; Pankuch GA; Credito KL; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2000 Feb; 44(2):304-10. PubMed ID: 10639354
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in Canada during 2000.
Low DE; de Azavedo J; Weiss K; Mazzulli T; Kuhn M; Church D; Forward K; Zhanel G; Simor A; McGeer A
Antimicrob Agents Chemother; 2002 May; 46(5):1295-301. PubMed ID: 11959559
[TBL] [Abstract][Full Text] [Related]
14. Susceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 Pneumococci from 10 central and Eastern European countries.
Nagai K; Appelbaum PC; Davies TA; Kelly LM; Hoellman DB; Andrasevic AT; Drukalska L; Hryniewicz W; Jacobs MR; Kolman J; Miciuleviciene J; Pana M; Setchanova L; Thege MK; Hupkova H; Trupl J; Urbaskova P
Antimicrob Agents Chemother; 2002 Feb; 46(2):371-7. PubMed ID: 11796344
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of ABT-773 versus macrolides and quinolones against resistant respiratory tract pathogens.
Dubois J; St -Pierre C
Diagn Microbiol Infect Dis; 2001; 40(1-2):35-40. PubMed ID: 11448561
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients.
Alcaide F; Carratala J; Liñares J; Gudiol F; Martin R
Antimicrob Agents Chemother; 1996 Sep; 40(9):2117-20. PubMed ID: 8878591
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of telithromycin against viridans group streptococci and Streptococcus bovis isolated from blood: antimicrobial susceptibility patterns in different groups of species.
Rodríguez-Avial I; Rodríguez-Avial C; Culebras E; Picazo JJ
Antimicrob Agents Chemother; 2005 Feb; 49(2):820-3. PubMed ID: 15673778
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of the in vitro activity of a new fluoroquinolone, ABT-492.
Harnett SJ; Fraise AP; Andrews JM; Jevons G; Brenwald NP; Wise R
J Antimicrob Chemother; 2004 May; 53(5):783-92. PubMed ID: 15056651
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America.
Diekema DJ; Beach ML; Pfaller MA; Jones RN;
Clin Microbiol Infect; 2001 Mar; 7(3):152-7. PubMed ID: 11318814
[TBL] [Abstract][Full Text] [Related]
20. High incidence of erythromycin-resistant streptococci in Taiwan.
Wu JJ; Lin KY; Hsueh PR; Liu JW; Pan HI; Sheu SM
Antimicrob Agents Chemother; 1997 Apr; 41(4):844-6. PubMed ID: 9087502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
